Emily Chan, MD, PhD

Title(s)ASST PROF OF CLIN-HCOMP, Pathology
SchoolSchool of Medicine
ORCID ORCID Icon0000-0002-7290-4004 Additional info
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. HER2 overexpression in urothelial carcinoma with GATA3 and PPARG copy number gains. Oncologist. 2024 Jun 22. Zhu X, Chan E, Turski ML, Mendez CE, Hsu SC, Kumar V, Shipp C, Jindal T, Chang K, Onodera C, Devine WP, Grenert JP, Stohr BA, Ding CC, Stachler MD, Quigley DA, Feng FY, Chu CE, Porten SP, Chou J, Friedlander TW, Koshkin VS. PMID: 38908022.
      View in: PubMed   Mentions:    Fields:    
    2. Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage. Histopathology. 2024 Jun 03. Nguyen JK, Harik LR, Klein EA, Li J, Corrigan D, Liu S, Chan E, Hawley S, Auman H, Newcomb LF, Carroll PR, Cooperberg MR, Filson CP, Simko JP, Nelson PS, Tretiakova MS, Troyer D, True LD, Vakar-Lopez F, Weight CJ, Lin DW, Brooks JD, McKenney JK. PMID: 38828674.
      View in: PubMed   Mentions:    Fields:    
    3. Morphologic patterns observed in prostate biopsy cases with discrepant grade group and molecular risk classification. Prostate. 2024 Aug; 84(11):1076-1085. Greenland NY, Cooperberg MR, Carroll PR, Cowan JE, Simko JP, Stohr BA, Chan E. PMID: 38734990.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. GATA3 Expression in Prostatic Adenosquamous Carcinoma: A Potential Diagnostic Pitfall. Int J Surg Pathol. 2024 Apr 01; 10668969241241640. Potterveld SK, Williamson SR, Al-Obaidy KI, Akgul M, Chan E, Giannico GA, Sangoi AR. PMID: 38562047.
      View in: PubMed   Mentions:    Fields:    
    5. Clinicopathologic and Molecular Characterization of High-Risk Human Papillomavirus-Positive Carcinomas of the Urinary Tract. Arch Pathol Lab Med. 2024 Apr 01. Kayraklioglu N, Stohr BA, Chan E. PMID: 38555943.
      View in: PubMed   Mentions:    Fields:    
    6. CD46-Targeted Theranostics for PET and 225Ac-Radiopharmaceutical Therapy of Multiple Myeloma. Clin Cancer Res. 2024 03 01; 30(5):1009-1021. Wadhwa A, Wang S, Patiño-Escobar B, Bidkar AP, Bobba KN, Chan E, Meher N, Bidlingmaier S, Su Y, Dhrona S, Geng H, Sarin V, VanBrocklin HF, Wilson DM, He J, Zhang L, Steri V, Wong SW, Martin TG, Seo Y, Liu B, Wiita AP, Flavell RR. PMID: 38109209; PMCID: PMC10905524.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    7. Development of CD46 targeted alpha theranostics in prostate cancer using 134Ce/225Ac-Macropa-PEG4-YS5. Theranostics. 2024; 14(4):1344-1360. Bobba KN, Bidkar AP, Wadhwa A, Meher N, Drona S, Sorlin AM, Bidlingmaier S, Zhang L, Wilson DM, Chan E, Greenland NY, Aggarwal R, VanBrocklin HF, He J, Chou J, Seo Y, Liu B, Flavell RR. PMID: 38389832; PMCID: PMC10879874.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    8. Diagnosis and management of neuroendocrine prostate cancer. Prostate. 2024 Apr; 84(5):426-440. de Kouchkovsky I, Chan E, Schloss C, Poehlein C, Aggarwal R. PMID: 38173302.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs. Neuro Oncol. 2023 12 08; 25(12):2221-2236. Williams EA, Ravindranathan A, Gupta R, Stevers NO, Suwala AK, Hong C, Kim S, Yuan JB, Wu J, Barreto J, Lucas CG, Chan E, Pekmezci M, LeBoit PE, Mully T, Perry A, Bollen A, Van Ziffle J, Devine WP, Reddy AT, Gupta N, Basnet KM, Macaulay RJB, Malafronte P, Lee H, Yong WH, Williams KJ, Juratli TA, Mata DA, Huang RSP, Hiemenz MC, Pavlick DC, Frampton GM, Janovitz T, Ross JS, Chang SM, Berger MS, Jacques L, Song JS, Costello JF, Solomon DA. PMID: 37436963; PMCID: PMC10708934.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    10. Large cribriform glands (> 0.25 mm diameter) as a predictor of adverse pathology in men with Grade Group 2 prostate cancer. Histopathology. 2024 Mar; 84(4):614-623. Greenland NY, Cowan JE, Stohr BA, Simko JP, Carroll PR, Chan E. PMID: 38012532.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Evaluating Web-Based Care for Mental Health and Substance Use Issues for Lesbian, Gay, Bisexual, Transgender, Queer, Questioning, and 2-Spirit Youths in the Context of the COVID-19 Pandemic: Community-Based Participatory Research Study. J Med Internet Res. 2023 11 17; 25:e44292. Chaiton M, Thorburn R, Chan E, Copeland I, Luphuyong C, Feng P. PMID: 37319010; PMCID: PMC10692883.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    12. Somatic mosaic SOX10 indel mutations underlie a form of segmental schwannomatosis. Acta Neuropathol. 2023 12; 146(6):857-860. Terry M, Gupta R, Ravindranathan A, Wu J, Chan E, Bollen AW, Chang SM, Berger MS, Jacques L, Solomon DA. PMID: 37821623; PMCID: PMC10627975.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Positive NKX3.1 as a diagnostic pitfall for prostate cancer in extramammary Paget's disease of genitourinary sites. Histopathology. 2024 Feb; 84(3):565-569. Chen CV, Francois RA, Mully TW, Sangoi A, LeBoit PE, Simko JP, Chan E. PMID: 37794658.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Wilms Tumor: An Unexpected Diagnosis in Adult Patients. Arch Pathol Lab Med. 2023 Sep 26. Chan GJ, Stohr BA, Osunkoya AO, Croom NA, Cho SJ, Balassanian R, Charu V, Bean GR, Chan E. PMID: 37756569.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Transcriptomic Heterogeneity of Expansile Cribriform and Other Gleason Pattern 4 Prostate Cancer Subtypes. Eur Urol Oncol. 2024 Apr; 7(2):222-230. Chappidi MR, Sjöström M, Greenland NY, Cowan JE, Baskin AS, Shee K, Simko JP, Chan E, Stohr BA, Washington SL, Nguyen HG, Quigley DA, Davicioni E, Feng FY, Carroll PR, Cooperberg MR. PMID: 37474400.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    16. Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study. Mod Pathol. 2023 Oct; 36(10):100241. Patel P, Harmon S, Iseman R, Ludkowski O, Auman H, Hawley S, Newcomb LF, Lin DW, Nelson PS, Feng Z, Boyer HD, Tretiakova MS, True LD, Vakar-Lopez F, Carroll PR, Cooperberg MR, Chan E, Simko J, Fazli L, Gleave M, Hurtado-Coll A, Thompson IM, Troyer D, McKenney JK, Wei W, Choyke PL, Bratslavsky G, Turkbey B, Siemens DR, Squire J, Peng YP, Brooks JD, Jamaspishvili T. PMID: 37343766; PMCID: PMC10592257.
      View in: PubMed   Mentions:    Fields:    
    17. Covalent Proteins as Targeted Radionuclide Therapies Enhance Antitumor Effects. ACS Cent Sci. 2023 Jun 28; 9(6):1241-1251. Klauser PC, Chopra S, Cao L, Bobba KN, Yu B, Seo Y, Chan E, Flavell RR, Evans MJ, Wang L. PMID: 37396859; PMCID: PMC10311652.
      View in: PubMed   Mentions: 7  
    18. Impact of Squamous Histology on Clinical Outcomes and Molecular Profiling in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors or Enfortumab Vedotin. Clin Genitourin Cancer. 2023 10; 21(5):e394-e404. Jindal T, Zhang L, Deshmukh P, Reyes K, Chan E, Kumar V, Zhu X, Maldonado E, Feng S, Johnson M, Angelidakis A, Kwon D, Desai A, Borno HT, Bose R, Wong A, Hong J, Carroll P, Meng M, Porten S, Aggarwal R, Small EJ, Fong L, Chou J, Friedlander T, de Kouchkovsky I, Koshkin VS. PMID: 37316414.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    19. Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy. Clin Cancer Res. 2023 05 15; 29(10):1916-1928. Bidkar AP, Wang S, Bobba KN, Chan E, Bidlingmaier S, Egusa EA, Peter R, Ali U, Meher N, Wadhwa A, Dhrona S, Dasari C, Beckford-Vera D, Su Y, Tang R, Zhang L, He J, Wilson DM, Aggarwal R, VanBrocklin HF, Seo Y, Chou J, Liu B, Flavell RR. PMID: 36917693; PMCID: PMC10183825.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    20. Epithelioid Angiomyolipoma With Prominent Papillary Architecture Mimicking Renal Cell Carcinoma: A Case Report. Int J Surg Pathol. 2024 Feb; 32(1):206-208. Xiao A, Van Ziffle J, Chan E. PMID: 37160913; PMCID: PMC10804686.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. IgG4-Related Prostatitis: A Potentially Underappreciated Finding for Pathologists. Int J Surg Pathol. 2024 Feb; 32(1):100-103. Sangoi AR, Maclean F, Myint E, Chan E. PMID: 37143307.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Urothelial carcinoma in situ with "overriding" features can evade detection by mimicking umbrella cells. Hum Pathol. 2023 06; 136:56-62. Bahceci D, Nguyen JK, Sangoi AR, Stohr BA, Chan E. PMID: 36997033.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer. Cancer Res. 2023 01 18; 83(2):301-315. Chou J, Egusa EA, Wang S, Badura ML, Lee F, Bidkar AP, Zhu J, Shenoy T, Trepka K, Robinson TM, Steri V, Huang J, Wang Y, Small EJ, Chan E, Stohr BA, Ashworth A, Delafontaine B, Rottey S, Cooke KS, Hashemi Sadraei N, Yu B, Salvati M, Bailis JM, Feng FY, Flavell RR, Aggarwal R. PMID: 36351060; PMCID: PMC10263373.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    24. Clear cell renal cell carcinoma with focal psammomatous calcifications: a rare occurrence mimicking translocation carcinoma. Histopathology. 2023 Apr; 82(5):684-690. Sangoi AR, Al-Obaidy KI, Cheng L, Kao CS, Chan E, Sadasivan S, Levin AM, Alvarado-Cabrero I, Kunju LP, Mehra R, Mannan R, Wang X, Dhillon J, Tretiakova M, Smith SC, Hes O, Williamson SR. PMID: 36564980.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Scoping Review of Racial and Ethnic Representation of Participants in Mental Health Research Conducted in the Perinatal Period During the COVID-19 Pandemic. J Obstet Gynecol Neonatal Nurs. 2023 03; 52(2):117-127. Goyal D, Dol J, Leckey M, Naraine S, Dennis CL, Chan EK, Basu G. PMID: 36462529; PMCID: PMC9710717.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    26. Molecular characterization of adenocarcinomas arising in the urinary bladder following augmentation cystoplasty: a multi-institutional study. Hum Pathol. 2022 11; 129:98-102. Stohr BA, Chan E, Anderson JA, Matoso A, Murati Amador BI, Cheng L, Osunkoya AO. PMID: 36108931; PMCID: PMC10403953.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Prostatic malakoplakia: clinicopathological assessment of a multi-institutional series of 49 patients. Histopathology. 2022 Oct; 81(4):520-528. Acosta AM, Sangoi AR, Maclean F, Trpkov K, Osunkoya AO, Collins K, Miyamoto H, Hirsch MS, Chan E, Tretiakova M, Mohanty SK, Kaushal S, Cornejo KM, Aron M, Quiroga-Garza G, Arora K, Nguyen JK, Williamson SR, Epstein JI, Matoso A. PMID: 35876721.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. Real-World Study of Characteristics and Treatment Outcomes Among Patients with KRAS p.G12C-Mutated or Other KRAS Mutated Metastatic Colorectal Cancer. Oncologist. 2022 08 05; 27(8):663-674. Fakih M, Tu H, Hsu H, Aggarwal S, Chan E, Rehn M, Chia V, Kopetz S. PMID: 35472176; PMCID: PMC9355827.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    29. CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease. Clin Cancer Res. 2022 07 15; 28(14):3066-3075. Zhao N, Chopra S, Trepka K, Wang YH, Sakhamuri S, Hooshdaran N, Kim H, Zhou J, Lim SA, Leung KK, Egusa EA, Zhu J, Zhang L, Foye A, Sriram R, Chan E, Seo Y, Feng FY, Small EJ, Chou J, Wells JA, Aggarwal R, Evans MJ. PMID: 35604681; PMCID: PMC9288514.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    30. Not your usual tonsillitis: a lesson for recognizing primary tonsillar syphilis. Histopathology. 2022 09; 81(3):407-408. Wu R, Babik J, Russell M, van Zante A, Chan E. PMID: 35758191.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    31. Deep brain stimulation in a young child with GNAO1 mutation - Feasible and helpful. Surg Neurol Int. 2022; 13:285. Fung EL, Mo CY, Fung ST, Chan AY, Lau KY, Chan EK, Chan DY, Zhu XL, Chan DT, Poon WS. PMID: 35855141; PMCID: PMC9282786.
      View in: PubMed   Mentions: 1  
    32. An exploration in pitfalls in interpreting SDHB immunohistochemistry. Histopathology. 2022 Aug; 81(2):264-269. Ding CC, Chan S, Mak J, Umetsu SE, Simko JP, Ruiz-Cordero R, Saunders T, Chan E. PMID: 35546442.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    33. Case Report: Novel Biallelic Variants in the COL18A1 Gene in a Chinese Family With Knobloch Syndrome. Front Neurol. 2022; 13:853918. Chong SC, Yuen YP, Cao Y, Fan SS, Leung TY, Chan EKY, Zhu XL. PMID: 35693012; PMCID: PMC9178278.
      View in: PubMed   Mentions:
    34. Granulomas associated with renal neoplasms: A multi-institutional clinicopathological study of 111 cases. Histopathology. 2022 May; 80(6):922-927. Sangoi AR, Maclean F, Mohanty S, Hes O, Daniel R, Lal P, Canete-Portillo S, Magi-Galluzzi C, Cornejo KM, Collins K, Hwang M, Falzarano SM, Feely MM, Dababneh M, Harik L, Tretiakova M, Akgul M, Manucha V, Chan E, Kao CS, Siadat F, Arora K, Barkan G, Cheng L, Hirsch M, Lei L, Wasco M, Williamson SR, Acosta AM. PMID: 35347739.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    35. p53 null phenotype is a "positive result" in urothelial carcinoma in situ. Mod Pathol. 2022 09; 35(9):1287-1292. Sangoi AR, Chan E, Abdulfatah E, Stohr BA, Nguyen J, Trpkov K, Siadat F, Hirsch M, Falzarano S, Udager AM, Kunju LP. PMID: 35322193.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    36. APOBEC Mutational Signature and Tumor Mutational Burden as Predictors of Clinical Outcomes and Treatment Response in Patients With Advanced Urothelial Cancer. Front Oncol. 2022; 12:816706. Natesan D, Zhang L, Martell HJ, Jindal T, Devine P, Stohr B, Espinosa-Mendez C, Grenert J, Van Ziffle J, Joseph N, Umetsu S, Onodera C, Turski M, Chan E, Desai A, Aggarwal R, Wong A, Porten S, Chou J, Friedlander T, Fong L, Small EJ, Sweet-Cordero A, Koshkin VS. PMID: 35321431; PMCID: PMC8935010.
      View in: PubMed   Mentions: 5  
    37. Papillary Renal Cell Carcinoma With Microcystic Architecture Is Strongly Associated With Extrarenal Invasion and Metastatic Disease. Am J Surg Pathol. 2022 03 01; 46(3):392-403. Chan E, Stohr BA, Butler RS, Cox RM, Myles JL, Nguyen JK, Przybycin CG, Reynolds JP, Williamson SR, McKenney JK. PMID: 34881751.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    38. Gods and monsters: Greek mythology and Christian references in the neurosurgical lexicon. Surg Neurol Int. 2022; 13:67. Woo PYM, Au D, Ko NMW, Wu O, Chan EKY, Cheng KKF, Wong AKS, Kirollos RW, Ribas G, Chan KY. PMID: 35242433; PMCID: PMC8888308.
      View in: PubMed   Mentions:
    39. TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells. Eur Urol Oncol. 2022 12; 5(6):714-718. Chou J, Trepka K, Sjöström M, Egusa EA, Chu CE, Zhu J, Chan E, Gibb EA, Badura ML, Contreras-Sanz A, Stohr BA, Meng MV, Pruthi RS, Lotan Y, Black PC, Porten SP, Koshkin VS, Friedlander TW, Feng FY. PMID: 35216942; PMCID: PMC10262920.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    40. Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinoma. Mod Pathol. 2022 08; 35(8):1092-1100. Chan E, McKenney JK, Hawley S, Corrigan D, Auman H, Newcomb LF, Boyer HD, Carroll PR, Cooperberg MR, Klein E, Fazli L, Gleave ME, Hurtado-Coll A, Simko JP, Nelson PS, Thompson IM, Tretiakova MS, Troyer D, True LD, Vakar-Lopez F, Lin DW, Brooks JD, Feng Z, Nguyen JK. PMID: 35145197; PMCID: PMC9314256.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    41. Molecular risk classifier score and biochemical recurrence risk are associated with cribriform pattern type in Gleason 3+4=7 prostate cancer. Investig Clin Urol. 2022 01; 63(1):27-33. Greenland NY, Cooperberg MR, Wong AC, Chan E, Carroll PR, Simko JP, Stohr BA. PMID: 34983120; PMCID: PMC8756156.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    42. Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients. Mod Pathol. 2022 06; 35(6):836-849. Fuchs TL, Maclean F, Turchini J, Vargas AC, Bhattarai S, Agaimy A, Hartmann A, Kao CS, Ellis C, Bonert M, Leroy X, Kunju LP, Schwartz L, Matsika A, Williamson SR, Rao P, Divatia M, Guarch R, Algaba F, Balancin ML, Zhou M, Samaratunga H, da Cunha IW, Brimo F, Ryan A, Clouston D, Aron M, O'Donnell M, Chan E, Hirsch MS, Moch H, Pang CY, Wah C, Yin W, Perry-Keene J, Yilmaz A, Chou A, Clarkson A, van der Westhuizen G, Morrison E, Zwi J, Hes O, Trpkov K, Gill AJ. PMID: 34949766.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    43. Differential immunohistochemical and molecular profiling of conventional and aggressive components of chromophobe renal cell carcinoma: pitfalls for diagnosis. Hum Pathol. 2022 01; 119:85-93. Chen CV, Croom NA, Simko JP, Stohr BA, Chan E. PMID: 34800526.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    44. TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor. J Immunother Cancer. 2021 05; 9(5). de Kouchkovsky I, Zhang L, Philip EJ, Wright F, Kim DM, Natesan D, Kwon D, Ho H, Ho S, Chan E, Porten SP, Wong AC, Desai A, Huang FW, Chou J, Oh DY, Pruthi RS, Fong L, Small EJ, Friedlander TW, Koshkin VS. PMID: 33980590; PMCID: PMC8118032.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    45. Prostate biopsy histopathologic features correlate with a commercial gene expression assay's reclassification of patient NCCN risk category. Prostate. 2020 12; 80(16):1421-1428. Greenland NY, Cowan JE, Chan E, Carroll PR, Stohr BA, Simko JP. PMID: 32946625.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    46. Invasive poorly differentiated adenocarcinoma of the bladder following augmentation cystoplasty: a multi-institutional clinicopathological study. Pathology. 2021 Feb; 53(2):214-219. Anderson JA, Matoso A, Murati Amador BI, Cheng L, Stohr BA, Chan E, Osunkoya AO. PMID: 32951908; PMCID: PMC9281534.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    47. The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma. Am J Surg Pathol. 2020 08; 44(8):e87-e99. van Leenders GJLH, van der Kwast TH, Grignon DJ, Evans AJ, Kristiansen G, Kweldam CF, Litjens G, McKenney JK, Melamed J, Mottet N, Paner GP, Samaratunga H, Schoots IG, Simko JP, Tsuzuki T, Varma M, Warren AY, Wheeler TM, Williamson SR, Iczkowski KA, ISUP Grading Workshop Panel Members. PMID: 32459716; PMCID: PMC7382533.
      View in: PubMed   Mentions: 123     Fields:    Translation:Humans
    48. Invasive plasmacytoid urothelial carcinoma: A comparative study of E-cadherin and P120 catenin. Hum Pathol. 2020 08; 102:54-59. Sangoi AR, Chan E, Stohr BA, Kunju LP. PMID: 32673685.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    49. Prevalence and associated factors for carriage of Enterobacteriaceae producing ESBLs or carbapenemase and methicillin-resistant Staphylococcus aureus in Hong Kong community. J Infect. 2020 08; 81(2):242-247. Kwok KO, Chan E, Chung PH, Tang A, Wei WI, Zhu C, Riley S, Ip M. PMID: 32447008.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    50. Molecular characterisation of metanephric adenomas beyond BRAF: genetic evidence for potential malignant evolution. Histopathology. 2020 Jun; 76(7):1084-1090. Chan E, Stohr BA, Croom NA, Cho SJ, Garg K, Troxell ML, Higgins JP, Bean GR. PMID: 32064677.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    51. Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer. Mod Pathol. 2020 09; 33(9):1802-1810. Chan E, Garg K, Stohr BA. PMID: 32313185.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    52. Expansile cribriform Gleason pattern 4 has histopathologic and molecular features of aggressiveness and greater risk of biochemical failure compared to glomerulation Gleason pattern 4. Prostate. 2020 05; 80(8):653-659. Greenland NY, Cowan JE, Zhang L, Carroll PR, Chan E, Stohr BA, Simko JP. PMID: 32220141.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    53. STAT6 monoclonal antibody is highly specific for the distinction between solitary fibrous tumour and prostatic stromal proliferations. Histopathology. 2020 03; 76(4):625-626. Cox RM, Chan E, Sangoi AR, Zou Y, McKenney JK. PMID: 31498908.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    54. A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-deficient Renal Cell Carcinoma in 32 Patients. Am J Surg Pathol. 2020 01; 44(1):98-110. Lau HD, Chan E, Fan AC, Kunder CA, Williamson SR, Zhou M, Idrees MT, Maclean FM, Gill AJ, Kao CS. PMID: 31524643.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    55. Detailed Morphologic and Immunohistochemical Characterization of Myomectomy and Hysterectomy Specimens From Women With Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC). Am J Surg Pathol. 2019 09; 43(9):1170-1179. Chan E, Rabban JT, Mak J, Zaloudek C, Garg K. PMID: 31162287.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    56. Beyond Depth of Invasion: Adverse Pathologic Tumor Features in Early Oral Tongue Squamous Cell Carcinoma. Laryngoscope. 2020 07; 130(7):1715-1720. Larson AR, Kemmer J, Formeister E, El-Sayed I, Ha P, George J, Ryan W, Chan E, Heaton C. PMID: 31411752.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    57. Prospective Detection of Germline Mutation of Fumarate Hydratase in Women With Uterine Smooth Muscle Tumors Using Pathology-based Screening to Trigger Genetic Counseling for Hereditary Leiomyomatosis Renal Cell Carcinoma Syndrome: A 5-Year Single Institutional Experience. Am J Surg Pathol. 2019 05; 43(5):639-655. Rabban JT, Chan E, Mak J, Zaloudek C, Garg K. PMID: 30741757.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    58. Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial. JAMA. 2019 04 09; 321(14):1370-1379. Ng K, Nimeiri HS, McCleary NJ, Abrams TA, Yurgelun MB, Cleary JM, Rubinson DA, Schrag D, Miksad R, Bullock AJ, Allen J, Zuckerman D, Chan E, Chan JA, Wolpin BM, Constantine M, Weckstein DJ, Faggen MA, Thomas CA, Kournioti C, Yuan C, Ganser C, Wilkinson B, Mackintosh C, Zheng H, Hollis BW, Meyerhardt JA, Fuchs CS. PMID: 30964527; PMCID: PMC6459117.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansCTClinical Trials
    59. Phase I Study of AMG 337, a Highly Selective Small-molecule MET Inhibitor, in Patients with Advanced Solid Tumors. Clin Cancer Res. 2019 Apr 15; 25(8):2403-2413. Hong DS, LoRusso P, Hamid O, Janku F, Kittaneh M, Catenacci DVT, Chan E, Bekaii-Saab T, Gadgeel SM, Loberg RD, Amore BM, Hwang YC, Tang R, Ngarmchamnanrith G, Kwak EL. PMID: 30425090; PMCID: PMC6892342.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    60. Improved diagnostic precision of urine cytology by implementation of The Paris System and the use of cell blocks. Cancer Cytopathol. 2018 09; 126(9):809-816. Chan E, Balassanian R, Tabatabai ZL, Lou H, Vohra P. PMID: 30203925.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    61. Therapeutic Targeting of the CBP/p300 Bromodomain Blocks the Growth of Castration-Resistant Prostate Cancer. Cancer Res. 2017 10 15; 77(20):5564-5575. Jin L, Garcia J, Chan E, de la Cruz C, Segal E, Merchant M, Kharbanda S, Raisner R, Haverty PM, Modrusan Z, Ly J, Choo E, Kaufman S, Beresini MH, Romero FA, Magnuson S, Gascoigne KE. PMID: 28819026.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansAnimalsCells
    62. Angiocentric glioma with MYB-QKI fusion located in the brainstem, rather than cerebral cortex. Acta Neuropathol. 2017 Oct; 134(4):671-673. Chan E, Bollen AW, Sirohi D, Van Ziffle J, Grenert JP, Kline CN, Tihan T, Perry A, Gupta N, Solomon DA. PMID: 28776091; PMCID: PMC5693679.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    63. Value of histopathology for predicting the post-operative complications of ileo-anal anastomosis (J-pouch) procedure in children with refractory ulcerative colitis. Pathology. 2016 Jun; 48(4):330-5. El Demellawy D, El Hallani S, de Nanassy J, Lee JY, Chan E, Sullivan K, Bass J, Mack D, Nasr A. PMID: 27130833.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    64. A phase I study of continuous oral dosing of OSI-906, a dual inhibitor of insulin-like growth factor-1 and insulin receptors, in patients with advanced solid tumors. Clin Cancer Res. 2015 Feb 15; 21(4):701-11. Puzanov I, Lindsay CR, Goff L, Sosman J, Gilbert J, Berlin J, Poondru S, Simantov R, Gedrich R, Stephens A, Chan E, Evans TR. PMID: 25212606.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCTClinical Trials
    65. Polarized exocyst-mediated vesicle fusion directs intracellular lumenogenesis within the C. elegans excretory cell. Dev Biol. 2014 Oct 01; 394(1):110-21. Armenti ST, Chan E, Nance J. PMID: 25102190; PMCID: PMC4373406.
      View in: PubMed   Mentions: 31     Fields:    Translation:AnimalsCells
    66. Mechanisms of CDC-42 activation during contact-induced cell polarization. J Cell Sci. 2013 Apr 01; 126(Pt 7):1692-702. Chan E, Nance J. PMID: 23424200; PMCID: PMC3647442.
      View in: PubMed   Mentions: 27     Fields:    Translation:Animals
    67. Safety, pharmacokinetics and pharmacodynamics of the anti-A33 fully-human monoclonal antibody, KRN330, in patients with advanced colorectal cancer. Eur J Cancer. 2013 Apr; 49(6):1169-75. Infante JR, Bendell JC, Goff LW, Jones SF, Chan E, Sudo T, Burris HA, Berlin JD. PMID: 23294608.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    68. Safety and pharmacokinetics of ganitumab (AMG 479) combined with sorafenib, panitumumab, erlotinib, or gemcitabine in patients with advanced solid tumors. Clin Cancer Res. 2012 Jun 15; 18(12):3414-27. Rosen LS, Puzanov I, Friberg G, Chan E, Hwang YC, Deng H, Gilbert J, Mahalingam D, McCaffery I, Michael SA, Mita AC, Mita MM, Mulay M, Shubhakar P, Zhu M, Sarantopoulos J. PMID: 22510349.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    69. Anaerobic degradation of benzene, toluene, ethylbenzene, and xylene compounds by Dechloromonas strain RCB. Appl Environ Microbiol. 2005 Dec; 71(12):8649-55. Chakraborty R, O'Connor SM, Chan E, Coates JD. PMID: 16332859; PMCID: PMC1317370.
      View in: PubMed   Mentions: 38     Fields:    Translation:Cells
    Emily's Networks
    Concepts (280)
    Derived automatically from this person's publications.
    _
    Co-Authors (97)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _